ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1797

Are Smoking and Alcohol Associated with Peripheral Musculoskeletal Involvement in Patients with Spondyloarthritis? Results from the ASAS-PerSpA Study

M.Lourdes Ladehesa-Pineda1, Rafaela Ortega2, Mara ngeles Puche Larrubia1, Maxime Dougados3, Eduardo Collantes-Estevez2 and Clementina López Medina4, 1Hospital Universitario Reina Sofía, Córdoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 3Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 4Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France

Meeting: ACR Convergence 2021

Keywords: alcohol, Enthesitis, Psoriatic arthritis, Smoking, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster IV: Clinical Aspects of PsA & Peripheral SpA (1773–1800)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: There are controversies around the role of smoking in manifestations of axial spondyloarthritis (axSpA) such as peripheral involvement. It has been observed an inverse association between alcohol consumption and disease activity and functional impairment, although it is still unclear its association with peripheral manifestations of SpA. Objectives: 1) To evaluate the association between smoking/alcohol intake and the prevalence of peripheral articular manifestations (i.e., arthritis, enthesitis or dactylitis); 2) to assess the association between smoking/alcohol intake and the specific location of such manifestations.

Methods: Patients from the cross-sectional ASAS-PerSpA study with available data for both the smoking status and alcohol intake were included. Mixed logistic regressions using the peripheral manifestation (or the location) as a dependent variable, the smoking status or alcohol intake and the presence of psoriasis as fixed effect and the country as random effect were used. The interaction between smoking and alcohol was tested.

Results: A total of 4451 patients with either axSpA, peripheral SpA or Psoriatic Arthritis were included in the analysis. 59.5% had smoked at any moment and 42.7% had been alcohol drinkers. Patients who have ever suffered arthritis showed a lower frequency of smoking habit (OR 0.72, 95%CI 0.63-0.82) and a lower alcohol consumption(OR 0.82, 95%CI 0.71-0.94) (table 1). In addition, among patients with arthritis, smoking was associated with a predominantly upper limbs involvement (OR 0.78, 95%CI 0.65-0.94), while alcohol was associated with a predominant mono/oligoarticular involvement (OR 1.13, 95%CI 0.94-1.36).

Patients who have ever suffered enthesitis also showed a lower frequency of smoking habit and alcohol intake (OR 0.75, 95%CI 0.63-0.89 and OR 0.69, 95%CI 0.57-0.83, respectively). No association was found with regard to the prevalence of dactylitis.

At the moment of the study visit, 20.4% patients were current smokers and 32.2% consumed alcohol. Current alcohol intake was associated with a lower prevalence of both current arthritis (26.9% vs. 33.6% (OR 0.76, 95%CI 0.64-0.91)) and current enthesitis (21.1% vs. 34.6% (OR 0.78, 95%CI 0.62-0.96)), while current smoking did not show significant differences.

No interaction was found in the association between alcohol and tobacco with regard to the prevalence of peripheral symptoms in the past. However, when assessing current arthritis, current smokers and no drinkers were found to be associated with arthritis in the lower limbs.

Conclusion: Taking into account the country and the presence of psoriasis, smoking and alcohol are associated with a lower prevalence of peripheral manifestations. Smoking seems to be associated with predominantly upper limbs arthritis while alcohol intake seems to be associated with a predominantly oligo/mono articular involvement. Future studies are required including the influence of psoriatic arthritis in the relationship between alcohol and smoking and its association with peripheral manifestations.


Disclosures: M. Ladehesa-Pineda, None; R. Ortega, None; M. Puche Larrubia, None; M. Dougados, AbbVie, 2, 5, Bristol-Myers Squibb, 2, 5, Eli Lilly, 2, 5, Merck, 2, 5, Novartis, 2, 5, Pfizer Inc, 2, 5, Roche, 2, 5, UCB, 2, 5; E. Collantes-Estevez, None; C. López Medina, None.

To cite this abstract in AMA style:

Ladehesa-Pineda M, Ortega R, Puche Larrubia M, Dougados M, Collantes-Estevez E, López Medina C. Are Smoking and Alcohol Associated with Peripheral Musculoskeletal Involvement in Patients with Spondyloarthritis? Results from the ASAS-PerSpA Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/are-smoking-and-alcohol-associated-with-peripheral-musculoskeletal-involvement-in-patients-with-spondyloarthritis-results-from-the-asas-perspa-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-smoking-and-alcohol-associated-with-peripheral-musculoskeletal-involvement-in-patients-with-spondyloarthritis-results-from-the-asas-perspa-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology